# Propanc Biopharma, Inc.: Form 8-K, filed Jul 15, 2015

- Company: [Propanc Biopharma, Inc.](/companies/ppcb.md) (CIK 1517681)
- Form: 8-K
- Filed: 2015-07-15
- Accepted by EDGAR: Jul 15, 2015, 08:03 ET
- Period: 2014-06-16
- Accession: 0001144204-15-042591
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1517681/000114420415042591/v415484_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517681/000114420415042591/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1517681/000114420415042591/v415484_8k.htm

Filed Jul 15, 2015.
Source: SEC EDGAR, the filing index for accession 0001144204-15-042591. Last ingested by Listed: Oct 29, 2026, 17:01 ET. No prices; not investment advice.